Meeting
2019 ASCO Annual Meeting
Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study.
Authors
Alison M. Schram
Memorial Sloan Kettering Cancer Center, New York, NY
Alison M. Schram , Ryma Benayed , Romel Somwar , Natasha Rekhtman , Maria E. Arcila , Marc Ladanyi , David Michael Hyman , Alexander E. Drilon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3129)
DOI
10.1200/JCO.2019.37.15_suppl.3129
Abstract #
3129
Poster Bd #
121
Abstract Disclosures
Similar Posters
First Author: Stephen V. Liu
Poster
2024 ASCO Annual Meeting
Detection of comprehensive oncogenic driver alteration of non-small cell lung cancer from cytology specimens by multi-gene PCR panel.
First Author: Tetsuya Sakai
First Author: Brinda Gupta
Poster
2023 ASCO Annual Meeting
Effects of mutations in SWI/SNF subunits on context-specific prognosis in driver positive and driver negative NSCLC.
First Author: Benjamin Herzberg